Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center

Background: The introduction of trastuzumab biosimilars in clinical practice plays an important role in promoting the sustainability of healthcare systems. By contrast, the switching process can be challenging to the clinics. This survey describes the switching process at a National Cancer Institute...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmaceutics
Hlavní autoři: Piezzo, Michela, D’Aniello, Roberta, Avallone, Ilaria, Barba, Bruno, Cianniello, Daniela, Cocco, Stefania, D’Avino, Antonio, Di Gioia, Germira, Di Lauro, Vincenzo, Fusco, Giuseppina, Piscitelli, Raffaele, von Arx, Claudia, De Laurentiis, Michelino, Maiolino, Piera
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8151152/
https://ncbi.nlm.nih.gov/pubmed/34068626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13050684
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky